Lupin Ltd. Sees Significant Open Interest Surge Amid Bullish Market Momentum

Open Interest and Volume Dynamics

On 24 June 2026, Lupin Ltd. recorded an open interest of 29,809 contracts in its derivatives, marking a substantial increase of 3,258 contracts or 12.27% compared to the previous OI of 26,551. This rise in OI was accompanied by a volume of 29,677 contracts, closely matching the open interest figure, which indicates fresh positions being established rather than merely the unwinding of existing ones.

The futures segment alone accounted for a value of approximately ₹66,429 lakhs, while the options segment exhibited a significantly larger notional value of ₹23,806 crore, culminating in a total derivatives value of ₹68,835 lakhs. Such elevated activity in both futures and options underscores heightened speculative and hedging interest in Lupin’s stock.

Price Performance and Technical Positioning

Lupin’s underlying share price closed at ₹2,378, just 4.79% shy of its 52-week high of ₹2,494, reflecting strong price momentum. The stock has outperformed its sector by 0.75% on the day, delivering a 1.19% gain compared to the sector’s 0.23% and the Sensex’s 0.64% returns. Notably, Lupin has recorded gains over the past two consecutive sessions, accumulating a 1.71% return during this period.

Technically, Lupin is trading above all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — signalling a robust uptrend and positive investor sentiment. The rising delivery volume of 4.34 lakh shares on 23 June, which is 2.4% higher than the five-day average, further confirms growing investor participation and conviction in the stock’s near-term prospects.

Market Positioning and Investor Sentiment

The surge in open interest alongside rising volumes suggests that market participants are increasingly positioning themselves for a potential upward move in Lupin’s stock price. The increase in OI by over 12% is a strong indicator of fresh capital entering the derivatives market, which often precedes significant price action.

Given Lupin’s mid-cap status with a market capitalisation of ₹1,09,086.54 crore, the stock offers a blend of growth potential and liquidity, making it attractive for both institutional and retail investors. The liquidity profile supports sizeable trade sizes, with the stock capable of handling trades worth ₹4.16 crore based on 2% of the five-day average traded value.

Furthermore, Lupin’s Mojo Score of 77.0 and a current Mojo Grade of Buy, recently downgraded from Strong Buy on 25 May 2026, reflects a cautious but positive outlook. This adjustment suggests that while the stock remains attractive, investors should be mindful of potential volatility or near-term consolidation.

Derivative Market Insights: Futures and Options

The futures value of ₹66,429 lakhs and the options value exceeding ₹23,806 crore highlight the significant hedging and speculative activity in Lupin’s derivatives. The large notional value in options indicates that traders are actively using calls and puts to express directional views or hedge existing positions.

Open interest increases in both futures and options typically point to a strengthening trend. In Lupin’s case, the rising OI coupled with price appreciation suggests that bullish bets are being placed, possibly anticipating further gains as the stock approaches its 52-week high.

Investors should also note the balance between call and put open interest to gauge market sentiment more precisely. While detailed strike-wise data is not available here, the overall increase in OI and volume supports a tilt towards positive directional bets.

Sector and Broader Market Context

Lupin’s outperformance relative to its Pharmaceuticals & Biotechnology sector and the broader Sensex index underscores its relative strength in a competitive industry. The sector’s 1-day return of 0.23% pales in comparison to Lupin’s 1.19%, indicating that the stock is attracting disproportionate investor interest.

Pharmaceuticals & Biotechnology remains a key focus area for investors given ongoing innovation, regulatory approvals, and global demand for healthcare products. Lupin’s strong fundamentals, combined with its technical momentum and derivative market activity, position it favourably within this sector.

Investor Takeaway

For investors and traders, the recent surge in Lupin’s open interest and volume signals a potential continuation of the upward trend. The stock’s proximity to its 52-week high, coupled with strong moving average support and rising delivery volumes, suggests that bullish momentum is intact.

However, the downgrade from Strong Buy to Buy indicates a need for cautious optimism. Market participants should monitor derivative positioning closely, especially changes in call and put open interest, to better understand evolving sentiment and potential volatility.

Given Lupin’s mid-cap status and liquidity profile, it remains a viable candidate for both medium-term investors seeking growth and traders looking to capitalise on near-term price movements.

Conclusion

Lupin Ltd.’s recent open interest surge in derivatives, combined with strong price performance and rising investor participation, highlights a bullish market stance. The stock’s technical strength and sector outperformance reinforce its appeal, while the derivative market activity provides valuable insight into investor positioning and sentiment. As Lupin approaches its 52-week high, market participants should remain vigilant to shifts in open interest and volume patterns to navigate potential opportunities and risks effectively.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today